Abstract

Uterine cervical carcinoma is one of the most common malignancies occurring in females and although the longer survival provided by the advances in early diagnosis and effective treatment, 30% of the patients develop persistent or recurrent disease. Recurrent disease is defined by local tumor re-growth or development of nodal or distant metastases at least 6 months after the lesion has regressed. Recurrent disease can occur centrally in the uterus or vaginal vault, laterally in the pelvic wall, can present as pelvic and extra-pelvic lymph node disease and as distant metastases. Although CT can be useful for surveillance MR is the most accurate imaging tool for characterization of pelvic recurrence. MR findings depend on previous therapeutics so the knowledge of imaging features of surgery and of the irradiated pelvis are crucial. Dynamic contrast-enhanced subtraction MR and diffusion weighted images give a valuable contribute in differential diagnosis of pelvic recurrence and inflammatory effects of radiation therapy but biopsy and serial imaging may be warranted. The authors review the spectrum of imaging findings of recurrent cervical carcinoma.

Highlights

  • Cervical carcinoma still represents a significant public health problem

  • Patients with early stage cervical cancer treated with surgery or radiotherapy are likely to have a good prognosis [2]

  • Substantial treatment failure still occurs and about 30% of the patients treated for cervical carcinoma develop progressive or recurrent tumors

Read more

Summary

Executive Editors

This article was originally published in a journal by OMICS Publishing Group, and the attached copy is provided by OMICS Publishing Group for the author’s benefit and for the benefit of the author’s institution, for commercial/research/educational use including without limitation use in instruction at your institution, sending it to specific colleagues that you know, and providing a copy to your institution’s administrator.

Introduction
Imaging Surveillance
Tumor Recurrence
Central Tumor Recurrence
Pelvic Side Wall Recurrence
Lymph Node Recurrence
Distant Recurrent Disease
Conclusion
Findings
Submit your next manuscript and get advantages of OMICS Group submissions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.